Kate Burbury

4.3k total citations · 1 hit paper
86 papers, 2.3k citations indexed

About

Kate Burbury is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Kate Burbury has authored 86 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 28 papers in Genetics and 27 papers in Oncology. Recurrent topics in Kate Burbury's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers), Venous Thromboembolism Diagnosis and Management (15 papers) and Lymphoma Diagnosis and Treatment (15 papers). Kate Burbury is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers), Venous Thromboembolism Diagnosis and Management (15 papers) and Lymphoma Diagnosis and Treatment (15 papers). Kate Burbury collaborates with scholars based in Australia, United States and Canada. Kate Burbury's co-authors include David C. Wheeler, Colin Baigent, Constantine S. Tam, John F. Seymour, Marliese Alexander, David Westerman, Rodney J. Hicks, Bernhard Riedel, Michael MacManus and Mathias Bressel and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Kate Burbury

84 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma

2018 274 citations Constantine S. Tam, Mary Ann Anderson et al. profile →

Peers

Countries citing papers authored by Kate Burbury

Since Specialization

Citations

This map shows the geographic impact of Kate Burbury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate Burbury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate Burbury more than expected).

Fields of papers citing papers by Kate Burbury

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate Burbury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate Burbury. The network helps show where Kate Burbury may publish in the future.

Co-authorship network of co-authors of Kate Burbury

This figure shows the co-authorship network connecting the top 25 collaborators of Kate Burbury. A scholar is included among the top collaborators of Kate Burbury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate Burbury. Kate Burbury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphoma 2025 ·Blood Advances ·Sasanka M. Handunnetti, Amit Khot, Piers Blombery, Kate Burbury, Philip A. Thompson, David Ritchie, Rodney J. Hicks, (unknown), Rachel Koldej, Mathias Bressel, (unknown), David Westerman, Stephen Lade, Andrew W. Roberts, John F. Seymour, Constantine S. Tam, Mary Ann Anderson	0
2	Co-Design, Development, and Evaluation of a Mobile Solution to Improve Medication Adherence in Cancer: Design Science Research Approach 2024 ·JMIR Cancer ·(unknown), Nilmini Wickramasinghe, Abdur Rahim Mohammad Forkan, Prem Prakash Jayaraman, Kate Burbury, Clare O’Callaghan, (unknown), Penelope Schofield	8
3	Digital Solution to Support Medication Adherence and Self-Management in Patients with Cancer (SAMSON): Pilot Randomized Controlled Trial 2024 ·JMIR Formative Research ·(unknown), Nilmini Wickramasinghe, Prem Prakash Jayaraman, Kate Burbury, Marliese Alexander, (unknown), (unknown), Stephen Quinn, Abdur Rahim Mohammad Forkan, Penelope Schofield	2
4	Associations between non‐anaemic iron deficiency and outcomes following elective surgery for colorectal cancer: a prospective cohort study* 2024 ·Anaesthesia ·Lachlan F. Miles, (unknown), (unknown), (unknown), Sabine Braat, Adele Burgess, Stéphane Héritier, (unknown), Anna Parker, Toby Richards, Kate Burbury, David Story, (unknown)	1
5	Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions 2024 ·Blood ·Sasanka M. Handunnetti, Mary Ann Anderson, Kate Burbury, Philip A. Thompson, (unknown), Mathias Bressel, (unknown), Rodney J. Hicks, David Westerman, Stephen Lade, Christiane Pott, Rishu Agarwal, Rachel Koldej, David Ritchie, Martin Dreyling, Mark A. Dawson, Sarah‐Jane Dawson, John F. Seymour, Andrew W. Roberts, Constantine S. Tam	7
6	Safety and adherence to medications and self-care advice in oncology (SAMSON): pilot randomised controlled trial protocol 2024 ·BMJ Open ·(unknown), Nilmini Wickramasinghe, Prem Prakash Jayaraman, Kate Burbury, Marliese Alexander, (unknown), Stephen Quinn, (unknown), (unknown), Penelope Schofield	1
7	Co-designing a motivational interviewing training platform to enhance oncology healthcare professional communication 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Marliese Alexander, Nilmini Wickramasinghe, Kate Burbury, Prem Prakash Jayaraman, Penelope Schofield	1
8	Iron homeostasis governs erythroid phenotype in Polycythemia Vera 2023 ·Blood ·Cavan Bennett, Victoria E. Jackson, Anne Pettikiriarachchi, Thomas J. Hayman, Ute Schaeper, (unknown), Katherine Fielding, Ricardo Ataíde, Danielle Clucas, Andrew Baldi, Alexandra L. Garnham, Connie S.N. Li Wai Suen, Stephen J. Loughran, E. Joanna Baxter, Anthony R. Green, Warren S. Alexander, Melanie Bahlo, Kate Burbury, Ashley P. Ng, Sant‐Rayn Pasricha	2
9	ImmunoPET: IMaging of cancer imMUNOtherapy targets with positron Emission Tomography: a phase 0/1 study characterising PD-L1 with ⁸⁹ Zr-durvalumab (MEDI4736) PET/CT in stage III NSCLC patients receiving chemoradiation study protocol 2022 ·BMJ Open ·Fiona Hegi‐Johnson, Stacey E. Rudd, Christian Wichmann, Tim Akhurst, Peter Roselt, (unknown), Thomas John, Lisa Devereux, Paul S. Donnelly, Rodney J. Hicks, Andrew M. Scott, Daniel Steinfort, Stephen B. Fox, Benjamin J. Blyth, Sagun Parakh, Gerard G. Hanna, Jason Callahan, Kate Burbury, Michael MacManus	15
10	Investigation of Intervention Solutions to Enhance Adherence to Oral Anticancer Medicines in Adults: Overview of Reviews 2022 ·JMIR Cancer ·(unknown), Abdur Rahim Mohammad Forkan, Nilmini Wickramasinghe, Prem Prakash Jayaraman, Marliese Alexander, Kate Burbury, Penelope Schofield	9
11	The MDM2 antagonist idasanutlin in patients with polycythemia vera: results from a single-arm phase 2 study 2021 ·Blood Advances ·John Mascarenhas, Francesco Passamonti, Kate Burbury, Tarec Christoffer El‐Galaly, Aaron T. Gerds, Vikas Gupta, Brian Higgins, (unknown), Candice Jamois, Bruno Kovic, Ling‐Yuh Huw, (unknown), Margherita Maffioli, Ruben A. Mesa, Jeanne Palmer, Marta Bellini, David M. Ross, Alessandro M. Vannucchi, Abdulraheem Yacoub	16
12	Autologous stem cell transplantation for untreated transformed indolent B‐cell lymphoma in first remission: an international, multi‐centre propensity‐score‐matched study 2020 ·British Journal of Haematology ·(unknown), (unknown), Katharine L. Lewis, Preetesh Jain, Yun Qing, Lei Feng, Chan Y. Cheah, John F. Seymour, David Ritchie, Kate Burbury, Constantine S. Tam, Nathan Fowler, Luis Fayad, Jason R. Westin, Sattva S. Neelapu, Fredrick B. Hagemeister, Felipe Samaniego, (unknown), Loretta J. Nastoupil, Michael Dickinson	7
13	A cross-sectional survey of Australian anesthetists’ and surgeons’ perceptions of preoperative risk stratification and prehabilitation 2019 ·Canadian Journal of Anesthesia/Journal canadien d anesthésie ·(unknown), (unknown), Hilmy Ismail, Kate Burbury, Kwok M. Ho, (unknown), Alexander G. Heriot, Bernhard Riedel	12
14	The effect of tyrosine kinase inhibitor interruption and interferon use on pregnancy outcomes and long-term disease control in chronic myeloid leukemia 2019 ·Leukemia & lymphoma ·Masa Lasica, Abbey Willcox, Kate Burbury, David M. Ross, Susan Branford, Jason Butler, Robin Filshie, Henry Januszewicz, David Joske, Anthony K. Mills, David Simpson, Constantine S. Tam, Kerry Taylor, Anne-Marie Watson, Max Wolf, Andrew Grigg	15
15	Characteristics and Outcomes of Therapy-Related Myeloid Neoplasms after Peptide Receptor Radionuclide Therapy (PRRT) for Metastatic Neuroendocrine Neoplasm (NEN): A Single Centre Series 2019 ·Neuroendocrinology ·Isaac Goncalves, Kate Burbury, David Westerman, Piers Blombery, (unknown), Amir Iravani, (unknown), (unknown), Michael S. Hofman, Timothy Akhurst, Rodney J. Hicks, Grace Kong	2
16	Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: Case report 2015 ·Platelets ·Louise Kostos, Kate Burbury, Gaurav Srivastava, H. Miles Prince	25
17	Limited clinical benefit for surveillance PET-CT scanning in patients with histologically transformed lymphoma in complete metabolic remission following primary therapy 2014 ·Annals of Hematology ·Chan Y. Cheah, Michael Dickinson, Michael S. Hofman, Anupkumar George, David Ritchie, H. Miles Prince, David Westerman, Simon J. Harrison, Kate Burbury, Max Wolf, Henry Januszewicz, Kirsten Herbert, Dennis Carney, Constantine S. Tam, John F. Seymour	15
18	Thromboembolism in lung cancer – An area of urgent unmet need 2014 ·Lung Cancer ·Marliese Alexander, Sue Kirsa, Rory Wolfe, Michael MacManus, (unknown), Benjamin Solomon, Kate Burbury	29
19	Rasburicase Causing Severe Oxidative Hemolysis and Methemoglobinemia in a Patient with Previously Unrecognized Glucose-6-Phosphate Dehydrogenase Deficiency 2013 ·Acta Haematologica ·Chan Y. Cheah, Thomas E. Lew, John F. Seymour, Kate Burbury	25
20	Fibrinogen Melbourne 2012 ·Blood Coagulation & Fibrinolysis ·Chan Y. Cheah, Stephen O. Brennan, Hannah Kennedy, E. Januszewicz, Ellen Maxwell, Kate Burbury	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact